Evidence map›Paper›PMID 42272118›Full record

ArticleAdvanced healthcare materials2026

Coordination-Driven Cu

Lei Wang, Jiaqi Wu, Xiao Zhao, Tianming Wang, Minxiao Zhu, Qiaoyu Zhang, Chenyu Wang, Xing Zhang, Yi Jiang, Qingqiang Yao and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lei WangCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Jiaqi WuCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Xiao ZhaoDepartment of Orthopaedic Surgery, Institute of Digital Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Tianming WangDepartment of Orthopaedic Surgery, Institute of Digital Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Minxiao ZhuCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Qiaoyu ZhangDepartment of Orthopaedic Surgery, Institute of Digital Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Chenyu WangCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Xing ZhangDepartment of Orthopaedic Surgery, Nanjing First Hospital, Nanjing, China.
Yi JiangCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Qingqiang YaoDepartment of Orthopaedic Surgery, Institute of Digital Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Yilun WuCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Yi-Shen ZhuCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.ORCID https://orcid.org/0000-0002-2616-8501

Funding

National Key Research and Development Program of China 2023YFB3813000National Natural Science Foundation of China 22305117Natural Science Foundation of Jiangsu Province BK20220336Science and Technology Project of Jiangsu Province BE2022718
6 · The paper itself

Abstract

Infectious bone defects, characterized by persistent bacterial infection and impaired osteogenesis, remain a major clinical challenge. Here, a copper ion-peptide supramolecular hydrogel integrated with a 3D-printed polycaprolactone scaffold (CPSH@PCL) was developed for synergistic treatment of infectious bone defects. Cu

Indexed as

Anti-Bacterial AgentsBone RegenerationCopperHydrogelsOsteogenesisPeptidesPolyestersTissue ScaffoldsAnimalsBiofilmsCell DifferentiationMaleMesenchymal Stem CellsMethicillin-Resistant Staphylococcus aureusOsteoblastsPseudomonas aeruginosaAnti-Bacterial AgentsCopperHydrogelsPeptidespolycaprolactonePolyestersantibacterial activitycopper ion‐peptide supramolecular hydrogelsmesenchymal stem cellosteogenic regenerationoxidative stressreactive oxygen species

Identifiers

PMID42272118
PMCPMC13356556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.